Evidence map›Paper›PMID 39778039›Full record

ArticleBJU international2025

Navigating choices: understanding the decision-making journey of patients with localised kidney cancer.

Katharina Beyer, Lionne D F Venderbos, Monique J Roobol, Rachel H Giles, Paul Verhagen, Ravi Barod, Lisa M Wintner, Michael A S Jewett, Mieke Van Hemelrijck, Netty Kinsella

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BJU international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Katharina BeyerDepartment of Urology, Erasmus MC Cancer Institute Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.ORCID https://orcid.org/0009-0007-4787-9154
Lionne D F VenderbosDepartment of Urology, Erasmus MC Cancer Institute Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.ORCID https://orcid.org/0000-0002-4269-0623
Monique J RoobolDepartment of Urology, Erasmus MC Cancer Institute Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.ORCID https://orcid.org/0000-0001-6967-1708
Rachel H GilesDepartment of Endocrine Oncology, Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands.
Paul VerhagenDepartment of Urology, Erasmus MC Cancer Institute Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.
Ravi BarodSpecialist Centre for Kidney Cancer, Royal Free Hospital, London, UK.
Lisa M WintnerDepartment of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, Medical University of Innsbruck, Innsbruck, Austria.
Michael A S JewettInternational Kidney Cancer Coalition, Utrecht, The Netherlands.
Mieke Van HemelrijckTranslational Oncology and Urology Research (TOUR), King's College London, London, UK.ORCID https://orcid.org/0000-0002-7317-0858
Netty KinsellaDepartment of Urology, Royal Marsden Hospital, London, UK.

Funding

Kidney Cancer UK MVH220219Royal Marsden Cancer Charity
6 · The paper itself

Abstract

objectiveTo explore patients' experience of decision making regarding treatment of localised kidney cancer.

methodsA total of 21 patients with localised kidney cancer, across three countries, participated in either four focus groups or seven semi-structured interviews that lasted on average 2 h. Focus groups and interviews were all conducted in the participants' native language, recorded, transcribed and (if applicable) translated into English. Thematic analysis was used to develop a codebook and identify themes.

resultsAll participants expressed a desire to be actively involved in the treatment decision-making process. However, due to the emotional toll of the cancer journey, which often necessitates quick decisions, actively engaging in the decision-making process was described as challenging. The study revealed 12 key themes. These themes included the impact of diagnostic paths, patient characteristics, patient empowerment, health literacy, source of support, fear of recurrence, trust in treatment and healthcare providers, shared decision making (SDM), professional interaction, personal belief system, and organisational and administrative issues.

conclusionsThe findings highlight the complexity of decision making, underscoring the desire for patient involvement, SDM, and clear communication. We reveal a significant gap between research recommendations and clinical practice, emphasising the need to translate research findings to clinical application to enhance patient-centred care.

Indexed as

Decision MakingKidney NeoplasmsPatient ParticipationAdultAgedAged, 80 and overDecision Making, SharedFemaleFocus GroupsHealth LiteracyHumansMaleMiddle AgedQualitative Researchablationactive surveillancekidney cancernephrectomyshared decision makingtreatment decision making

Identifiers

PMID39778039
PMCPMC12053016

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.